{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:22:01Z","timestamp":1794529321102,"version":"4.9.1"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119100","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:34:37Z","timestamp":1770694477000},"page":"119100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["microRNAs in pancreatic cancer: Key modulators of tumor progression and therapeutic resistance"],"prefix":"10.1016","volume":"196","author":[{"given":"Hadi","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Kohkalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Amin","family":"Seyyed Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Kargarmonhaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Mahd Gharebagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Nikdouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-8539","authenticated-orcid":false,"given":"Arezoo","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12029-025-01183-2","article-title":"Trends in the global incidence of pancreatic cancer and a brief review of its histologic and molecular subtypes","volume":"56","author":"Leiphrakpam","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.biopha.2026.119100_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1460544","article-title":"Insights and therapeutic advances in pancreatic cancer: the role of electron microscopy in decoding the tumor microenvironment","volume":"12","author":"Dai","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"43","key":"10.1016\/j.biopha.2026.119100_bib4","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-018-0858-1","article-title":"Tumor microenvironment participates in metastasis of pancreatic cancer","volume":"17","author":"Ren","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","article-title":"The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119100_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.pmbts.2016.09.008","article-title":"Molecular Pathogenesis of Pancreatic Cancer","volume":"144","author":"Grant","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/genes10100752","article-title":"MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential","volume":"10","author":"Rawat","year":"2019","journal-title":"Genes"},{"issue":"22","key":"10.1016\/j.biopha.2026.119100_bib9","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.18632\/oncotarget.2624","article-title":"Critical role of NF-\u03baB in pancreatic cancer","volume":"5","author":"Prabhu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119100_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2018.02.011","article-title":"NF-\u03baB in pancreatic cancer: Its key role in chemoresistance","volume":"421","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib11","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.3390\/ijms25073914","article-title":"MicroRNAs in Pancreatic Cancer: Advances in Biomarker Discovery and Therapeutic Implications","volume":"25","author":"Madadjim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2009.11.010","article-title":"MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications","volume":"292","author":"Rachagani","year":"2010","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.biopha.2026.119100_bib13","doi-asserted-by":"crossref","first-page":"13340","DOI":"10.3390\/ijms241713340","article-title":"Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer\u2014Advances and Challenges","volume":"24","author":"Seyhan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119100_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.biopha.2026.119100_bib15","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/cells11152374","article-title":"MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions","volume":"11","author":"Prinz","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib16","first-page":"197","article-title":"miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer","volume":"27","author":"Qadir","year":"2017"},{"key":"10.1016\/j.biopha.2026.119100_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2014.09.006","article-title":"miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies","volume":"81","author":"Chitkara","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119100_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-60761-863-8_15","article-title":"The guideline of the design and validation of MiRNA mimics","volume":"676","author":"Wang","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119100_bib19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2147\/CMAR.S235794","article-title":"miR-455-3p functions as a tumor suppressor by restraining Wnt\/\u03b2-catenin signaling via TAZ in pancreatic cancer","author":"Zhan","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2026.119100_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.biopha.2018.05.091","article-title":"MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells","volume":"105","author":"Hu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib21","article-title":"Challenges and opportunities in microRNA-based cancer therapeutics","volume":"6","author":"Ju","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications","volume":"44","author":"Martino","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119100_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.critrevonc.2017.01.002","article-title":"The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting","volume":"111","author":"Jonckheere","year":"2017","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.biopha.2026.119100_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1012-4","article-title":"Small molecule KRAS agonist for mutant KRAS cancer therapy","volume":"18","author":"Xu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119100_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fonc.2015.00023","article-title":"Impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer","volume":"5","author":"Furukawa","year":"2015","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/bjc.2014.215","article-title":"Oncogenic KRAS signalling in pancreatic cancer","volume":"111","author":"Eser","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib29","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/carcin\/bgq160","article-title":"The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS","volume":"31","author":"Zhao","year":"2010","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2010.06.012","article-title":"miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2","volume":"298","author":"Ma","year":"2010","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.biopha.2026.119100_bib31","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1101\/gad.1950610","article-title":"Repression of the miR-143\/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway","volume":"24","author":"Kent","year":"2010","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/diseases12070152","article-title":"In Silico Identification of Dysregulated miRNAs Targeting KRAS Gene in Pancreatic Cancer","volume":"12","author":"Garibaldi-R\u00edos","year":"2024","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-014-0084-2","article-title":"MicroRNA-mediated regulation of KRAS in cancer","volume":"7","author":"Kim","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41420-023-01733-2","article-title":"Circular RNA hsa_circ_0001846 facilitates the malignant behaviors of pancreatic cancer by sponging miR-204-3p and upregulating KRAS expression","volume":"9","author":"Ma","year":"2023","journal-title":"Cell Death Discov."},{"issue":"14","key":"10.1016\/j.biopha.2026.119100_bib35","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.molcel.2023.06.008","article-title":"Oncogenic K-Ras suppresses global miRNA function","volume":"83","author":"Shui","year":"2023","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib36","article-title":"Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma","volume":"32","author":"Yuen","year":"2024","journal-title":"Mol. Ther. Oncol."},{"issue":"37","key":"10.1016\/j.biopha.2026.119100_bib37","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/onc.2014.408","article-title":"MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes","volume":"34","author":"Keklikoglou","year":"2015","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib38","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.18632\/oncotarget.6830","article-title":"Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923\/KRAS pathway","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/hum.2008.134","article-title":"let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression","volume":"20","author":"Torrisani","year":"2009","journal-title":"Hum. gene Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032068","article-title":"MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors","volume":"7","author":"Jiao","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2026.119100_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2014.10.020","article-title":"Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer","volume":"81","author":"Rachagani","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1593\/neo.04445","article-title":"Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis","volume":"7","author":"L\u00f6hr","year":"2005","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/fon-2015-0050","article-title":"Developments in miRNA gene signaling pathways in pancreatic cancer","volume":"12","author":"Vorvis","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2026.119100_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/sci.2017.01.01","article-title":"microRNA regulation of human pancreatic cancer stem cells","volume":"4","author":"Xu","year":"2017","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.biopha.2026.119100_bib46","series-title":"Seminars in cancer biology","article-title":"editors. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention","author":"Karmakar","year":"2019"},{"issue":"12","key":"10.1016\/j.biopha.2026.119100_bib47","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3390\/cancers16122179","article-title":"Extracellular vesicular miRNA in pancreatic cancer: from lab to therapy","volume":"16","author":"Tiwari","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119100_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1295936","article-title":"KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients","volume":"13","author":"Lavacchi","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","article-title":"More to life than NF-\u03baB in TNFR1 signaling","volume":"37","author":"Ting","year":"2016","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib50","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","article-title":"Molecular targets of dietary agents for prevention and therapy of cancer","volume":"71","author":"Aggarwal","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119100_bib51","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/sj.onc.1207332","article-title":"Secretion of cytokines and growth factors as a general cause of constitutive NF\u03baB activation in cancer","volume":"23","author":"Lu","year":"2004","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4161\/cc.3.9.1130","article-title":"Cytokine overexpression and constitutive NF\u03baB in cancer","volume":"3","author":"Lu","year":"2004","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cells7090133","article-title":"NFKB1 and cancer: friend or foe?","volume":"7","author":"Concetti","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119100_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2018.02.011","article-title":"NF-\u03baB in pancreatic cancer: Its key role in chemoresistance","volume":"421","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib55","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3892\/ijo.2017.3857","article-title":"MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells","volume":"50","author":"Zhou","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib56","first-page":"119","article-title":"The nuclear factor-\u03baB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells","volume":"5","author":"Wang","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib57","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.7150\/jca.73690","article-title":"RELA-Induced MiR-21 exerts oncogenic effects on PDAC via targeting of ARHGAP24","volume":"13","author":"Yu","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2026.119100_bib58","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s10620-017-4472-7","article-title":"MiR-143 targeting TAK1 attenuates pancreatic ductal adenocarcinoma progression via MAPK and NF-\u03baB pathway in vitro","volume":"62","author":"Huang","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/15384047.2022.2054257","article-title":"The NF-\u03baB\/miR-488\/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling","volume":"23","author":"Han","year":"2022","journal-title":"Cancer Biol. Ther."},{"issue":"17","key":"10.1016\/j.biopha.2026.119100_bib60","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1158\/1078-0432.CCR-09-1942","article-title":"New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts","volume":"16","author":"Li","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib61","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"miR-146a suppresses invasion of pancreatic cancer cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/emboj.2010.296","article-title":"miR-301a as an NF-\u03baB activator in pancreatic cancer cells","volume":"30","author":"Lu","year":"2011","journal-title":"EMBO J."},{"issue":"25","key":"10.1016\/j.biopha.2026.119100_bib63","doi-asserted-by":"crossref","first-page":"21148","DOI":"10.18632\/oncotarget.4125","article-title":"Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"25","key":"10.1016\/j.biopha.2026.119100_bib64","doi-asserted-by":"crossref","first-page":"21046","DOI":"10.18632\/oncotarget.4124","article-title":"MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4","volume":"6","author":"Xia","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib65","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/ijo.2014.2243","article-title":"MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells","volume":"44","author":"Funamizu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087897","article-title":"MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha","volume":"9","author":"Huang","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib67","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pan.2013.06.007","article-title":"Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells","volume":"13","author":"Takiuchi","year":"2013","journal-title":"Pancreatology"},{"key":"10.1016\/j.biopha.2026.119100_bib68","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.biopha.2018.12.121","article-title":"MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8","volume":"111","author":"Mou","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"42","key":"10.1016\/j.biopha.2026.119100_bib69","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2016.90","article-title":"Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1\/Akt\/NF-\u03baB signaling","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib70","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/biomedicines10071692","article-title":"Therapeutic miR-506-3p replacement in pancreatic carcinoma leads to multiple effects including autophagy, apoptosis, senescence, and mitochondrial alterations in vitro and in vivo","volume":"10","author":"Borchardt","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119100_bib71","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2018.00546","article-title":"MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib72","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/MPA.0b013e3181ba82e1","article-title":"Antisense inhibition of microRNA-21 or-221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma","volume":"38","author":"Park","year":"2009","journal-title":"Pancreas"},{"issue":"5458","key":"10.1016\/j.biopha.2026.119100_bib73","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1126\/science.287.5458.1606","article-title":"Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus","volume":"287","author":"Peifer","year":"2000","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.biopha.2026.119100_bib74","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.3390\/ijms20174242","article-title":"Wnt\/\u03b2-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance","volume":"20","author":"Ram Makena","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib75","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1172\/JCI40045","article-title":"\u03b2-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice","volume":"120","author":"Morris","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib76","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"issue":"5933","key":"10.1016\/j.biopha.2026.119100_bib77","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib78","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1096\/fj.07-102855","article-title":"Human tumor nanoparticles induce apoptosis of pancreatic cancer cells","volume":"22","author":"Ristorcelli","year":"2008","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib79","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.canlet.2010.10.015","article-title":"Targeting apoptosis pathways in pancreatic cancer","volume":"332","author":"Arlt","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib80","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib81","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s13238-010-0112-0","article-title":"Wnt pathway antagonists and angiogenesis","volume":"1","author":"Zhang","year":"2010","journal-title":"Protein Cell"},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib82","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1053\/j.gastro.2010.08.022","article-title":"KLF4\u03b1 up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer","volume":"139","author":"Wei","year":"2010","journal-title":"Gastroenterology"},{"issue":"35","key":"10.1016\/j.biopha.2026.119100_bib83","doi-asserted-by":"crossref","first-page":"37557","DOI":"10.18632\/oncotarget.5317","article-title":"MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt\/\u03b2-catenin pathway","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119100_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174006","article-title":"Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma","volume":"901","author":"Lotfi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib85","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3892\/ijo.2013.2037","article-title":"MicroRNA-29a induces resistance to gemcitabine through the Wnt\/\u03b2-catenin signaling pathway in pancreatic cancer cells","volume":"43","author":"Nagano","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib86","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.18632\/oncotarget.3089","article-title":"Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype","volume":"6","author":"Jiang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119100_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820945801","article-title":"MiR-331-3p links to drug resistance of pancreatic cancer cells by activating WNT\/\u03b2-Catenin signal via ST7L","volume":"19","author":"Zhan","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"issue":"13","key":"10.1016\/j.biopha.2026.119100_bib88","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-12-3859","article-title":"Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer","volume":"73","author":"Kong","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2014.04.048","article-title":"Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and \u03b2-catenin signaling in pancreatic ductal adenocarcinoma cells","volume":"147","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib90","first-page":"755","article-title":"miRNA\u201127a promotes the proliferation and inhibits apoptosis of human pancreatic cancer cells by Wnt\/\u03b2-catenin pathway","volume":"39","author":"Cui","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119100_bib91","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.biopha.2016.06.057","article-title":"Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3\u03b2 and sFRP1 in human pancreatic carcinoma","volume":"83","author":"Yang","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/ijo.2023.5594","article-title":"Function of microRNA-124 in the pathogenesis of cancer","volume":"64","author":"Liu","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119100_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132438","article-title":"Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions","volume":"16","author":"Argentiero","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042210","article-title":"Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment","volume":"22","author":"Raue","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119100_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117347","article-title":"Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential","volume":"179","author":"Helen","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib96","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1158\/0008-5472.CAN-10-2738","article-title":"DCAMKL-1 regulates epithelial\u2013mesenchymal transition in human pancreatic cells through a miR-200a\u2013dependent mechanism","volume":"71","author":"Sureban","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib97","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/ijo.2020.5145","article-title":"MicroRNA\u2011301a\/ZNRF3\/wnt\/\u03b2\u2011catenin signal regulatory crosstalk mediates glioma progression","volume":"58","author":"Sun","year":"2021","journal-title":"Int J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib98","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220503","article-title":"WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer","volume":"220","author":"Du","year":"2022","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13472-y","article-title":"Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-\u03b2-catenin pathway","volume":"12","author":"Roy","year":"2022","journal-title":"Sci. Rep."},{"issue":"40","key":"10.1016\/j.biopha.2026.119100_bib100","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1038\/s41388-019-0908-1","article-title":"PORCN inhibition synergizes with PI3K\/mTOR inhibition in Wnt-addicted cancers","volume":"38","author":"Zhong","year":"2019","journal-title":"Oncogene"},{"issue":"5-6","key":"10.1016\/j.biopha.2026.119100_bib101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000108959","article-title":"Basics of TGF-\u03b2 and pancreatic cancer","volume":"7","author":"Truty","year":"2007","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jcm6010005","article-title":"The TGF-\u03b2\/Smad4 signaling pathway in pancreatic carcinogenesis and its clinical significance","volume":"6","author":"Ahmed","year":"2017","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib103","first-page":"4222","article-title":"Transforming growth factor \u03b21 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation","volume":"61","author":"Ellenrieder","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mc.20827","article-title":"Aberrant signaling pathways in pancreatic cancer: a two compartment view","volume":"51","author":"McCleary-Wheeler","year":"2012","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2026.119100_bib105","first-page":"383","article-title":"Tumor-suppressor genes in pancreatic cancer","volume":"5","author":"Hruban","year":"1998","journal-title":"J. hepatoBiliaryPancreat. Surg."},{"issue":"5247","key":"10.1016\/j.biopha.2026.119100_bib106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4, a candidate tumor suppressor gene at human chromosome 18q21. 1","volume":"271","author":"Hahn","year":"1996","journal-title":"science"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib107","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","article-title":"TGF-\u03b2 tumor suppression through a lethal EMT","volume":"164","author":"David","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119100_bib108","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-010-1147-x","article-title":"The TGF-\u03b2\/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system","volume":"128","author":"Wiercinska","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"14","key":"10.1016\/j.biopha.2026.119100_bib109","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/1078-0432.CCR-09-0227","article-title":"SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer","volume":"15","author":"Blackford","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib110","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","article-title":"DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer","volume":"27","author":"Iacobuzio-Donahue","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119100_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-4-560","article-title":"A study of Smad4, Smad6 and Smad7 in surgically resected samples of pancreatic ductal adenocarcinoma and their correlation with clinicopathological parameters and patient survival","volume":"4","author":"Singh","year":"2011","journal-title":"BMC Res. Notes"},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib112","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1541-7786.MCR-16-0327","article-title":"miR-202 diminishes TGF\u03b2 receptors and attenuates TGF\u03b21-induced EMT in pancreatic cancer","volume":"15","author":"Mody","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib113","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.febslet.2010.11.039","article-title":"MicroRNA 483-3p suppresses the expression of DPC4\/Smad4 in pancreatic cancer","volume":"585","author":"Hao","year":"2011","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib114","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbrc.2011.02.086","article-title":"MicroRNA 421 suppresses DPC4\/Smad4 in pancreatic cancer","volume":"406","author":"Hao","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib115","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/ng.3634","article-title":"Subgenome parallel selection is associated with morphotype diversification and convergent crop domestication in Brassica rapa and Brassica oleracea","volume":"48","author":"Cheng","year":"2016","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib116","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib117","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ncb1905","article-title":"A SNAIL1\u2013SMAD3\/4 transcriptional repressor complex promotes TGF-\u03b2 mediated epithelial\u2013mesenchymal transition","volume":"11","author":"Vincent","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"5715","key":"10.1016\/j.biopha.2026.119100_bib118","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.1105718","article-title":"Regulation of the polarity protein Par6 by TGF\u03b2 receptors controls epithelial cell plasticity","volume":"307","author":"Ozdamar","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib119","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s12672-025-03220-9","article-title":"Role of the TGF-\u03b2\/Smad3 pathway in pancreatic cancer cell growth and stem cell characteristics","volume":"16","author":"Zhang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib120","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1074\/jbc.M105105200","article-title":"A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-\u03b2 signaling","volume":"277","author":"Bai","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.200307151","article-title":"GADD34\u2013PP1c recruited by Smad7 dephosphorylates TGF\u03b2 type I receptor","volume":"164","author":"Shi","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119100_bib122","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1245\/s10434-008-0284-5","article-title":"Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer","volume":"16","author":"Wang","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib123","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/bjc.2015.102","article-title":"miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-\u03b2 signalling pathway","volume":"112","author":"Zhu","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119100_bib124","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s12253-013-9637-x","article-title":"MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer","volume":"19","author":"Wu","year":"2013","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1159\/000430389","article-title":"MicroRNA-29a promotes pancreatic cancer growth by inhibiting tristetraprolin","volume":"37","author":"Sun","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib126","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41419-018-0839-8","article-title":"MiR-361-3p regulates ERK1\/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2026.119100_bib127","series-title":"Seminars in cancer biology","article-title":"editors. Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-\u03b2) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis","author":"Vivekanandhan","year":"2019"},{"key":"10.1016\/j.biopha.2026.119100_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-0963-2","article-title":"The miR-141\/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer","volume":"19","author":"Ma","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"38","key":"10.1016\/j.biopha.2026.119100_bib129","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/onc.2013.405","article-title":"microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-\u03b2 actions","volume":"33","author":"Ouyang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119100_bib130","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1007\/s12032-012-0175-2","article-title":"Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activation","volume":"29","author":"Du","year":"2012","journal-title":"Med. Oncol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119100_bib131","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/diagnostics13172769","article-title":"SMAD proteins in TGF-\u03b2 signalling pathway in cancer: regulatory mechanisms and clinical applications","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib132","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12935-021-02149-7","article-title":"Molecular mechanisms of the microRNA-132 during tumor progressions","volume":"21","author":"Moghbeli","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib133","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/cancers15030768","article-title":"Combination, modulation and interplay of modern radiotherapy with the tumor microenvironment and targeted therapies in pancreatic cancer: which candidates to boost radiotherapy?","volume":"15","author":"Benkhaled","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70292","article-title":"Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"issue":"31","key":"10.1016\/j.biopha.2026.119100_bib135","doi-asserted-by":"crossref","first-page":"10752","DOI":"10.3748\/wjg.v20.i31.10752","article-title":"Falasca M. Emerging role of the KRAS-PDK1 axis in pancreatic cancer","volume":"20","author":"Ferro","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.biopha.2026.119100_bib136","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00423-002-0314-x","article-title":"Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo","volume":"387","author":"Boehle","year":"2002","journal-title":"Lange 's. Arch. Surg."},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib137","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1002\/jcb.26861","article-title":"Roles of methyltrienolone (R1881) in AKTs and AR expression patterns of cultured granulosa-lutein cells","volume":"119","author":"Nekoonam","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib138","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3233\/CBM-181196","article-title":"Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells","volume":"22","author":"Wang","year":"2018","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib139","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13062-023-00368-8","article-title":"circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K\/AKT signaling pathway","volume":"18","author":"Xu","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.biopha.2026.119100_bib140","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.biopha.2018.10.177","article-title":"Dysregulation of key microRNAs in pancreatic cancer development","volume":"109","author":"Baradaran","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib141","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/1566524011313040001","article-title":"MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3","volume":"13","author":"Liu","year":"2013","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib142","first-page":"1473","article-title":"Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol","volume":"33","author":"Paik","year":"2013","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib143","first-page":"465","article-title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27kip1, p57kip2, and PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib144","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jhg.2016.59","article-title":"MicroRNA in pancreatic cancer","volume":"62","author":"Yonemori","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.biopha.2026.119100_bib145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13402-016-0275-7","article-title":"Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application","volume":"39","author":"Taucher","year":"2016","journal-title":"Cell. Oncol."},{"issue":"5-6","key":"10.1016\/j.biopha.2026.119100_bib146","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3727\/096504013X13589503482734","article-title":"MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro","volume":"20","author":"Zhou","year":"2012","journal-title":"Oncol. Res."},{"key":"10.1016\/j.biopha.2026.119100_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0315-3","article-title":"RETRACTED ARTICLE: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer","volume":"14","author":"Zang","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib148","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","article-title":"Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer","volume":"21","author":"Gu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib149","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10565-022-09736-y","article-title":"miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR\/AKT\/PI3K pathway in pancreatic cancer","volume":"39","author":"Guo","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib150","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/cancers14112812","article-title":"Team UPR. Cancer-associated fibroblasts confer gemcitabine resistance to pancreatic cancer cells through PTEN-targeting miRNAs in exosomes","volume":"14","author":"Richards","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib151","doi-asserted-by":"crossref","first-page":"G309","DOI":"10.1152\/ajpgi.00322.2019","article-title":"microRNA-382 suppresses the progression of pancreatic cancer through the PI3K\/Akt signaling pathway by inhibition of Anxa3","volume":"319","author":"Wan","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib152","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/15384047.2019.1702401","article-title":"Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT","volume":"21","author":"Xu","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2026.119100_bib153","article-title":"MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells","author":"Ghasaban","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib154","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1582-4934.2009.00748.x","article-title":"Apoptosis pathways and their therapeutic exploitation in pancreatic cancer","volume":"13","author":"Fulda","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"55","key":"10.1016\/j.biopha.2026.119100_bib155","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1038\/sj.onc.1208951","article-title":"TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity","volume":"24","author":"Tomasini","year":"2005","journal-title":"Oncogene"},{"issue":"41","key":"10.1016\/j.biopha.2026.119100_bib156","doi-asserted-by":"crossref","first-page":"16170","DOI":"10.1073\/pnas.0703942104","article-title":"Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development","volume":"104","author":"Gironella","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib157","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.arcmed.2011.01.006","article-title":"Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells","volume":"42","author":"Dong","year":"2011","journal-title":"Arch. Med. Res."},{"issue":"41","key":"10.1016\/j.biopha.2026.119100_bib158","doi-asserted-by":"crossref","first-page":"43831","DOI":"10.18632\/oncotarget.6257","article-title":"The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib159","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3892\/or.2013.2297","article-title":"miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2","volume":"29","author":"Cai","year":"2013","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib160","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib161","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.25260","article-title":"miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines","volume":"127","author":"Zhu","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib162","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2861","article-title":"miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention","volume":"13","author":"Srivastava","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib163","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/wrna.1229","article-title":"MicroRNAs as therapeutic targets in human cancers","volume":"5","author":"Shah","year":"2014","journal-title":"Wiley Interdisciplinary Reviews RNA"},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib164","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA a cancer journal clinicians"},{"key":"10.1016\/j.biopha.2026.119100_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111914","article-title":"Emerging roles of miRNAs in the development of pancreatic cancer","volume":"141","author":"Fathi","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119100_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-33-54","article-title":"miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1","volume":"33","author":"Ma","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib167","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/biomedicines9101322","article-title":"The role of microRNA in pancreatic cancer","volume":"9","author":"Smolarz","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib168","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2010.03.004","article-title":"MiR-210\u2013micromanager of the hypoxia pathway","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib169","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/acsnano.9b03978","article-title":"Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA\/siRNA nanotherapy","volume":"14","author":"Xie","year":"2020","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2026.119100_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib171","first-page":"2798","article-title":"The effects of miRNA-1180 on suppression of pancreatic cancer","volume":"9","author":"Gu","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119100_bib172","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1007\/s13277-014-2271-8","article-title":"MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3","volume":"35","author":"Li","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.biopha.2026.119100_bib173","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1007\/s13277-014-2271-8","article-title":"MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3","volume":"35","author":"Li","year":"2014","journal-title":"Tumor Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib174","first-page":"222","article-title":"LncRNA GAS5 regulates gemcitabine resistance in pancreatic carcinoma by targeting miRNA-21","volume":"53","author":"Huang","year":"2023","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib175","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/cells13110948","article-title":"The multifaceted role of miR-21 in pancreatic cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib176","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10555-023-10127-w","article-title":"Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma","volume":"42","author":"Vahabi","year":"2023","journal-title":"Cancer Metastas. Rev."},{"issue":"22","key":"10.1016\/j.biopha.2026.119100_bib177","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/ijms21228823","article-title":"Emerging kinase therapeutic targets in pancreatic ductal adenocarcinoma and pancreatic cancer desmoplasia","volume":"21","author":"Creeden","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119100_bib178","series-title":"Nanopharmaceuticals","first-page":"151","article-title":"Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs","author":"Kova\u010devi\u0107","year":"2020"},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib179","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/acsnano.7b04734","article-title":"Next-generation lipids in RNA interference therapeutics","volume":"11","author":"Rietwyk","year":"2017","journal-title":"ACS nano"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib180","first-page":"289","article-title":"Modulating microRNAs in cancer: Next-generation therapies","volume":"19","author":"Arghiani","year":"2022","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib181","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/mt.2013.35","article-title":"Targeting miR-21 for the therapy of pancreatic cancer","volume":"21","author":"Sicard","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119100_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.05.007","article-title":"Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205","volume":"402","author":"Chaudhary","year":"2017","journal-title":"Cancer Lett."},{"issue":"01","key":"10.1016\/j.biopha.2026.119100_bib183","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CM9.0000000000001826","article-title":"MicroRNAs as potential therapeutic targets for pancreatic cancer","volume":"135","author":"Chu","year":"2022","journal-title":"Chin. Med. J."},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib184","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3390\/pharmaceutics15092363","article-title":"Advances in pancreatic cancer treatment by nano-based drug delivery systems","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib185","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/1535-7163.MCT-17-1090","article-title":"iRGD-guided tumor-penetrating nanocomplexes for therapeutic siRNA delivery to pancreatic cancer","volume":"17","author":"Lo","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib186","article-title":"Responsive Nanomaterial Delivery Systems for Pancreatic Cancer Management","volume":"7","author":"Elsherbeny","year":"2024","journal-title":"Adv. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib187","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/cas.13267","article-title":"Co-delivery of micro RNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy","volume":"108","author":"Li","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03187","article-title":"MiR-502 is the first reported miRNA simultaneously targeting two components of the classical non-homologous end joining (C-NHEJ) in pancreatic cell lines","volume":"6","author":"Smolinska","year":"2020","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib189","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/ol.2021.12561","article-title":"miR-153 enhances the therapeutic effect of radiotherapy by targeting JAG1 in pancreatic cancer cells","volume":"21","author":"Zhao","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119100_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01178-6","article-title":"Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer","volume":"19","author":"Jiang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.biopha.2026.119100_bib191","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3390\/cells11152294","article-title":"The influence of microRNA-31 on oxidative stress and radiosensitivity in pancreatic ductal adenocarcinoma","volume":"11","author":"McGrath","year":"2022","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.biopha.2026.119100_bib192","doi-asserted-by":"crossref","first-page":"17523","DOI":"10.3390\/ijms242417523","article-title":"Functional and potential therapeutic implication of microRNAs in pancreatic cancer","volume":"24","author":"Pal","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217421","article-title":"MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma","volume":"14","author":"Felix","year":"2019","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib194","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mt.2015.10","article-title":"The clinical relevance of the miR-197\/CKS1B\/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer","volume":"23","author":"Fujita","year":"2015","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib195","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-08-0507","article-title":"miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1","volume":"7","author":"Du","year":"2009","journal-title":"Mol. Cancer Res."},{"issue":"23","key":"10.1016\/j.biopha.2026.119100_bib196","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-018-0178-3","article-title":"miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy","volume":"37","author":"Xi","year":"2018","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2026.119100_bib197","doi-asserted-by":"crossref","first-page":"13502","DOI":"10.18632\/oncotarget.6284","article-title":"A double feedback loop mediated by microRNA-23a\/27a\/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression","volume":"7","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib198","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.4049\/jimmunol.1102001","article-title":"MicroRNA-125b potentiates macrophage activation","volume":"187","author":"Chaudhuri","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib199","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7537","key":"10.1016\/j.biopha.2026.119100_bib200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"MicroRNA silencing for cancer therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2026.119100_bib201","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib202","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21873\/anticanres.13144","article-title":"MicroRNA-based targeted therapeutics in pancreatic cancer","volume":"39","author":"Gurbuz","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2026.119100_bib203","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2019.11.010","article-title":"Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma","volume":"19","author":"Guo","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JP9.0000000000000029","article-title":"Development of microRNA-based therapy for pancreatic cancer","volume":"2","author":"Fesler","year":"2019","journal-title":"J. Pancreatol."},{"key":"10.1016\/j.biopha.2026.119100_bib205","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.47","article-title":"Mir-34: a new weapon against cancer?","volume":"3","author":"Misso","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib206","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib207","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41936-024-00360-2","article-title":"The potential of microRNAs in cancer diagnostic and therapeutic strategies: a narrative review","volume":"85","author":"Quang","year":"2024","journal-title":"J. Basic Appl. Zool."},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib208","doi-asserted-by":"crossref","first-page":"F673","DOI":"10.1152\/ajprenal.00251.2022","article-title":"Promises and challenges of miRNA therapeutics","volume":"323","author":"Long","year":"2022","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib209","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bph.17302","article-title":"Mitigating off-target effects of small RNAs: conventional approaches, network theory and artificial intelligence","volume":"182","author":"Bereczki","year":"2025","journal-title":"Br. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00018-017-2656-0","article-title":"Evaluation and control of miRNA-like off-target repression for RNA interference","volume":"75","author":"Seok","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119100_bib211","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41587-024-02480-0","article-title":"What will it take to get miRNA therapies to market?","volume":"42","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib212","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet"},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib213","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/nar\/gkae141","article-title":"Chemical modification patterns for microRNA therapeutic mimics: a structure-activity relationship (SAR) case-study on miR-200c","volume":"52","author":"Garreau","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib214","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-019-1629-z","article-title":"Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data","volume":"20","author":"Liu","year":"2019","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10555-023-10127-w","article-title":"Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma","volume":"42","author":"Vahabi","year":"2023","journal-title":"Cancer Metastas. Rev."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119100_bib216","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000477773","article-title":"Tumor Heterogeneity in Pancreatic Adenocarcinoma","volume":"85","author":"Cros","year":"2018","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib217","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1186\/s12885-024-13007-w","article-title":"Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models","volume":"24","author":"Fenu","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib218","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1038\/s41598-020-64569-1","article-title":"Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods","volume":"10","author":"Shams","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib219","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073996","article-title":"Circulating microRNAs in Medicine","volume":"23","author":"Pozniak","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib220","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1101\/gr.198788.115","article-title":"Degradation dynamics of microRNAs revealed by a novel pulse-chase approach","volume":"26","author":"Marzi","year":"2016","journal-title":"Genome Res"},{"issue":"173","key":"10.1016\/j.biopha.2026.119100_bib221","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/3-540-27262-3_21","article-title":"Locked nucleic acid: high-affinity targeting of complementary RNA for RNomics","volume":"173","author":"Kauppinen","year":"2006","journal-title":"Handb. Exp. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib222","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1432-1033.2003.03555.x","article-title":"Antisense technologies. Improvement through novel chemical modifications","volume":"270","author":"Kurreck","year":"2003","journal-title":"Eur. J. Biochem"},{"issue":"8","key":"10.1016\/j.biopha.2026.119100_bib223","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/138920101708160517234941","article-title":"Lipid Nanoparticles to Deliver miRNA in Cancer","volume":"17","author":"Campani","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib224","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s13346-019-00645-y","article-title":"Delivery of therapeutic miRNA using polymer-based formulation","volume":"9","author":"Ban","year":"2019","journal-title":"Drug Deliv. Transl. Res"},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/hgtb.2017.036","article-title":"Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors","volume":"28","author":"Herrera-Carrillo","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib226","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1021\/acs.molpharmaceut.7b00900","article-title":"Evaluation of MUC1-Aptamer Functionalized Hybrid Nanoparticles for Targeted Delivery of miRNA-29b to Nonsmall Cell Lung Cancer","volume":"15","author":"Perepelyuk","year":"2018","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib227","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: a changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib228","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2026.119100_bib229","series-title":"Nanoarchitectonics in Biomedicine","first-page":"411","article-title":"Chapter 12 - Targeted delivery systems for treatment of pancreatic cancer","author":"Karaca","year":"2019"},{"issue":"5","key":"10.1016\/j.biopha.2026.119100_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188779","article-title":"Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment","volume":"1877","author":"Sia","year":"2022","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119100_bib231","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib232","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119100_bib233","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of gene therapy","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.biopha.2026.119100_bib234","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15252\/emmm.201100899","article-title":"Development of microRNA therapeutics is coming of age","volume":"6","author":"van Rooij","year":"2014","journal-title":"EMBO Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cell.2014.02.045","article-title":"Transgenerational epigenetic inheritance: myths and mechanisms","volume":"157","author":"Heard","year":"2014","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2026.119100_bib236","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119100_bib237","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"issue":"6","key":"10.1016\/j.biopha.2026.119100_bib238","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119100_bib239","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib240","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cam4.626","article-title":"Micro RNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD 4","volume":"5","author":"Wei","year":"2016","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119100_bib241","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s10620-017-4472-7","article-title":"MiR-143 targeting TAK1 attenuates pancreatic ductal adenocarcinoma progression via MAPK and NF-\u03baB pathway in vitro","volume":"62","author":"Huang","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib242","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000447302","article-title":"The clinical significance of miR-34a in pancreatic ductal carcinoma and associated molecular and cellular mechanisms","volume":"84","author":"Long","year":"2016","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119100_bib243","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol. Mech. Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:50:07Z","timestamp":1781880607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":243,"alternative-id":["S0753332226001320"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119100","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"microRNAs in pancreatic cancer: Key modulators of tumor progression and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119100"}}